KEAL 2 g, oral suspension in a sachet 14 sachets of 10 ml
Active ingredients: Sucralfate
Commercialized according to BDPM
Oral suspension14 sachets of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KEAL 2 g, suspension buvable en sachet
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 14 sachet(s) papier polyéthylène aluminium de 10 ml
- Marketing authorisation holder
- EXOD
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Aug 2021
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60602431CIP73021262CIP133400930212622Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCRALFATEsuspension | 2 g · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.